Risultati della ricerca - Jason E. Hill

Raffina i risultati
  1. 1
    p53 Pathway in Renal Cell Carcinoma Is Repressed by a Dominant Mechanism

    p53 Pathway in Renal Cell Carcinoma Is Repressed by a Dominant Mechanism di Katerina V. Gurova, Jason E. Hill, Olga V. Razorenova, Peter M. Chumakov, Andrei V. Gudkov

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Molecular profile of <i>FLT3</i>-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib

    Molecular profile of <i>FLT3</i>-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib di Catherine C. Smith, Mark J. Levis, Alexander E. Perl, Jason E. Hill, Matt Rosales, Erkut Bahceci

    Pubblicazione 2022
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Similar patterns of cortical expansion during human development and evolution

    Similar patterns of cortical expansion during human development and evolution di Jason E. Hill, Terrie E. Inder, Jeffrey J. Neil, Donna Dierker, John Harwell, David C. Van Essen

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

    Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations di Theodore C. Tarver, Jason E. Hill, Leena Rahmat, Alexander E. Perl, Erkut Bahceci, Kenichi Mori, Catherine C. Smith

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Regional impairments of cortical folding in premature infants

    Regional impairments of cortical folding in premature infants di Erin Engelhardt, Terrie E. Inder, Dimitrios Alexopoulos, Donna Dierker, Jason E. Hill, David C. Van Essen, Jeffrey J. Neil

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Longitudinal Analysis of Neural Network Development in Preterm Infants

    Longitudinal Analysis of Neural Network Development in Preterm Infants di Christopher D. Smyser, Terrie E. Inder, Joshua S. Shimony, Jason E. Hill, Andrew J. Degnan, Abraham Z. Snyder, Jeffrey J. Neil

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    PCR-based subtractive hybridization and differences in gene content among strains of <i>Helicobacter pylori</i>

    PCR-based subtractive hybridization and differences in gene content among strains of <i>Helicobacter pylori</i> di Natalia S. Akopyants, Arkady F. Fradkov, Luda Diatchenko, Jason E. Hill, Paul D. Siebert, Sergey Lukyanov, E. D. Sverdlov, Douglas E. Berg

    Pubblicazione 1998
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells

    Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells di Neil L. Spector, Yosef Yarden, Bradley L. Smith, Ljuba Lyass, Patricia B. Trusk, Karen Pry, Jason E. Hill, Wenle Xia, Rony Seger, Sarah Bacus

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity

    ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity di Neru Munshi, Sébastien Jeay, Youzhi Li, Chang-Rung Chen, Dennis S. France, Mark A. Ashwell, Jason E. Hill, Magdi Moussa, David Leggett, Chiang J. Li

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Comparison of cortical folding measures for evaluation of developing human brain

    Comparison of cortical folding measures for evaluation of developing human brain di Joshua S. Shimony, Christopher D. Smyser, Graham Wideman, Dimitrios Alexopoulos, Jason E. Hill, John Harwell, Donna Dierker, David C. Van Essen, Terrie E. Inder, Jeffrey J. Neil

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer

    A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer di Wenle Xia, Sarah Bacus, Priti S. Hegde, Intisar Husain, Jay C. Strum, Leihua Liu, Georgina Paulazzo, Ljuba Lyass, Patricia B. Trusk, Jason E. Hill, Jennifer L. Harris, Neil L. Spector

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

    A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations di Mark J. Levis, Alexander E. Perl, Jessica K. Altman, Christopher D. Gocke, Erkut Bahceci, Jason E. Hill, Chaofeng Liu, Zhiyi Xie, Andrew R. Carson, Valerie McClain, Timothy T. Stenzel, Jeffrey E. Miller

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Maintenance therapy with the <i>FMS</i>‐like tyrosine kinase 3 inhibitor gilteritinib in patients with <i>FMS</i>‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study

    Maintenance therapy with the <i>FMS</i>‐like tyrosine kinase 3 inhibitor gilteritinib in patients with <i>FMS</i>‐like tyrosine kinase 3–internal tandem duplication acute myeloid l... di Emmanuel Gyan, Mark D. Minden, Kohmei Kubo, Alessandro Rambaldi, Gunnar Juliusson, Martin Jädersten, Richard Kelly, László Szerafin, Wensheng He, Stanley C. Gill, Jason E. Hill, Caroline Chen, David Delgado‐Gómez, Nahla Hasabou

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors

    Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors di Katerina V. Gurova, Jason E. Hill, Canhui Guo, Anatoly Prokvolit, Lyudmila G. Burdelya, E. M Samoylova, Anna V. Khodyakova, Ram Ganapathi, Mahrukh K. Ganapathi, Natalia D. Tararova, Dmitry A. Bosykh, Dmitriy Lvovskiy, Thomas R. Webb, George R. Stark, Andrei V. Gudkov

    Pubblicazione 2005
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML

    Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML di Keith W. Pratz, Mohamad Cherry, Jessica K. Altman, Brenda Cooper, Nikolai A. Podoltsev, José C. Cruz, Tara L. Lin, Gary J. Schiller, Joseph G. Jurcic, Adam Asch, Ruishan Wu, Jason E. Hill, Stanley C. Gill, Angela James, Elizabeth Rich, Nahla Hasabou, Alexander E. Perl, Mark J. Levis

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy

    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy di Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti‐Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu

    Pubblicazione 2022
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance

    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance di Vanessa E. Kennedy, Cheryl A.C. Peretz, Anushka Walia, Brenda Chyla, Yan Sun, Jason E. Hill, Elaine Tran, Andrew Koh, Timothy T. Ferng, Samantha M. Pintar, Matthew F. Jones, Bogdan Popescu, Natália Faraj Murad, Ritu Roy, Adam B. Olshen, Sunil Joshi, Elie Traer, Monique Dail, Habib Hamidi, Jessica K. Altman, Naval Daver, Mark J. Levis, James McCloskey, Alexander E. Perl, Catherine C. Smith

    Pubblicazione 2025
    Testo
    Pré-impressão
    Aggiungi alla lista
    Salvato in:
  18. 18
    A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

    A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors di Mari C. Vázquez‐Borrego, Vandana Gupta, Alejandro Ibáñez‐Costa, Manuel D. Gahete, Eva Venegas‐Moreno, Álvaro Toledano-Delgado, David A. Cano, Cristóbal Blanco-Acevedo, Rosa Ortega‐Salas, Miguel Á. Japón, Ana Barrera-Martín, Alexandre Vasiljevic, Jason E. Hill, Shengwen Zhang, Heather Halem, Juan Solivera, Gérald Raverot, María A. Gálvez, Alfonso Soto‐Moreno, Marcelo Páez-Pereda, Michael D. Culler, Justo P. Castaño, Raúl M. Luque

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML di Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Üstün, Masumi Ueda, Geoffrey L. Uy, Edmund K. Waller, Sumithira Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee‐Je Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Caroline Chen, Nahla Hasabou, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    A Large Set of Finnish Affected Sibling Pair Families With Type 2 Diabetes Suggests Susceptibility Loci on Chromosomes 6, 11, and 14

    A Large Set of Finnish Affected Sibling Pair Families With Type 2 Diabetes Suggests Susceptibility Loci on Chromosomes 6, 11, and 14 di Kaisa Silander, Laura J. Scott, Timo T. Valle, Karen L. Mohlke, Heather M. Stringham, Kerry Wiles, William L. Duren, Kimberly F. Doheny, Elizabeth Pugh, Peter S. Chines, Narisu Narisu, Peggy P. White, Tasha E. Fingerlin, Anne Jackson, Chun Li, Soumitra Ghosh, Victoria L. Magnuson, Kimberly Colby, Michael R. Erdos, Jason E. Hill, Pablo E. Hollstein, Kathleen M. Humphreys, Roshni A. Kasad, Jessica E. Lambert, Konstantinos N. Lazaridis, George Lin, Anabelle Morales‐Mena, Kristin Patzkowski, Carrie Pfahl, Rachel Porter, David Rha, Leonid Segal, Yong Suh, Jason P. Tovar, Arun M. Unni, Christian Welch, Julie A. Douglas, Michael P. Epstein, Elizabeth R. Hauser, William Hagopian, Thomas A. Buchanan, Richard M. Watanabe, Richard N. Bergman, Jaakko Tuomilehto, Francis S. Collins, Michael Boehnke

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: